WHO ICTRP trial
Biotin in the treatment of female hair loss
RBR-69qq9p · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Not Recruiting
Key facts
| Trial ID | RBR-69qq9p |
|---|---|
| Public title | Biotin in the treatment of female hair loss |
| Scientific title | A 24-week randomized, prospective, triple-blinded, placebo-controlled trial investigating the efficacy of 10 mg biotin in the treatment of chronic effluvium telogen in women |
| Primary sponsor | Paulo Ramos |
| Secondary sponsors | Faculdade Medicina da Universidade Estadual Paulista - UNESP |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Not Recruiting |
| Study type | Intervention |
| Phase | 2-3 |
| Countries | Brazil |
| Conditions | Telogen effluvium;L65.0 |
| Interventions | One hundred participants will be randomly randomized into two groups (block randomization, second list provided by computer program). One group will be instructed to take two 2.5 mg biotin capsules every 12 hours and another group will be… |
| Registration date | Jan 29, 2020 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: